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PCNA is a central scaffold that coordinately assembles replication and repair machineries at DNA replication forks for
faithful genome duplication. Here, we describe TRAIP (RNF206) as a novel PCNA-interacting factor that has important
roles during mammalian replicative stress responses. We show that TRAIP encodes a nucleolar protein that migrates to
stalled replication forks, and that this is accomplished by its targeting of PCNA via an evolutionarily conserved PIP box on
its C terminus. Accordingly, inactivation of TRAIP or its interaction with the PCNA clamp compromised replication fork
recovery and progression, and leads to chromosome instability. Together, our ﬁndings establish TRAIP as a component of
the mammalian replicative stress response network, and implicate the TRAIP-PCNA axis in recovery of stalled
replication forks.
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Introduction
The proliferating cell nuclear antigen (PCNA) has
central roles inDNA replication and repair processes [1].
In its homo-trimeric, ring-shaped conﬁguration, the
PCNA clamp tethers DNA polymerase δ and ε,
and slides along DNA to promote processive DNA
replication. In addition to docking core DNA
replication factors, PCNA is also a recruiting platform
for components of various DNA repair pathways,
including those that drive translesion bypass.
Consistent with roles in DNA repair processes,
hypomorphic mutation of PCNA has been associated
with clinical manifestations of human DNA repair
disorders, including neurodegeneration, short status
and photosensitivity [2].
The functionality of PCNA entails coordinated
opening of its ring structure, its loading onto DNA,
and the subsequent ATP hydrolysis-driven closing of
the clamp [3]. Although the molecular basis for the
assembly of the sliding clamp onto DNA is established
[4, 5], mechanisms that detail how PCNA is unloaded
have only recently emerged. Indeed, the ATAD5/Elg1-
replication factor C-like complex, which has long been
known to interact with the replication clamp, was
only recently implicated a PCNA-unloading function,
although its biochemistry remains undeﬁned [6–8].
Importantly, PCNA residency at replication forks
correlated with histone supply [9], and is negatively
regulated by cell exposure to replication inhibitors
hydroxyurea (HU) and aphidicolin [9–13]. In support
of coordinated unloading of PCNA during cell
responses to replicative stress, the DNA damage
kinases ATM/TEL1 and ATR/MEC1 have docu-
mented roles in active unloading of the clamp from
damaged forks [14]. Although it remains obscure how
PCNA is dynamically regulated, genetic mutations
that compromise its homeostasis at stress forks are
closely linked to defects in replication restart and
checkpoint control [15, 16].
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We arrived at TRAIP (aka. RNF206), a RING
domain-containing E3 ubiquitin ligase [17], as a factor
that localizes at DNA replication compartments
during our search for new players in DNA damage
responses (DDRs). Human TRAIP and its Drosophila
homolog NOPO are essential for cell proliferation and
organismal development [18–20]. Although TRAIP
was originally identiﬁed as a negative regulator of
NF-κB activation [21–24], the observations that nopo
embryos displayed spindle defects and arrested in
mitosis lend credence to the idea that NOPO/TRAIP
may be important in genome stability maintenance
[19]. This is further supported by the fact that
inactivation of the DNA damage checkpoint kinase
CHK2 alleviated the nopo-associated phenotypes [19],
suggesting that nopo cells may have prematurely
entered mitosis with under-replicated DNA [25].
Consistent with putative roles in replicative stress
responses, TRAIP was recently identiﬁed in a
proteome-wide study as a factor that concentrated at
stalled forks [26], and has been reported to interact
with Y-family translesion DNA polymerases, and via
undeﬁned mechanisms, promoted recruitment of
polymerase eta onto DNA lesions [27].
Results
TRAIP protects genome integrity
With an interest in exploring the putative roles
of TRAIP in genome integrity protection, we ﬁrst
examined whether TRAIP inactivation may affect
genome stability. Consistent with a recent report [28],
analysis of time-lapse ﬂuorescence microscopy
images of GFP-H2B-expressing HeLa cells revealed
an important role of TRAIP in promoting ordered
chromosome segregation, as TRAIP-depleted cells
displayed a marked increase in the number of
mitotic aberrations, including misaligned and lagging
chromosomes (Supplementary Figure S1A and B).
Although inactivation of TRAIP using two inde-
pendent small-interfering RNAs (siRNAs) did not
noticeably affect duration of and cell percentage in
mitosis (Supplementary Figure S1C and D), TRAIP
depletion resulted in a substantial increase in the
formation of micronuclei (Figure 1a and b) and gross
chromosomal aberrations (Figure 1c and d).
Flow-cytometric analysis of cell-cycle proﬁles also
revealed that the majority of TRAIP-depleted cells
accumulated in S and G2 phases of the cell cycle
(Figure 1e), suggesting that TRAIP may preserve
genome integrity during DNA replication [19, 27].
Finally, we found that TRAIP-depleted cells were
comparably hyper-responsive to HU treatment,
as determined by cell labeling using anti-γH2AX
antibodies (Figure 1f) and by clonogenic survival assay
(Figure 1g). Together, these observations support the
idea that TRAIP is a component of the mammalian
DDR network and is important for maintenance of
genome stability.
TRAIP resides in the nucleoli
Aside the possibility of residing in the cytoplasm
[21–23], TRAIP has also been reported to concentrate
in discrete nuclei foci [19, 27–31]. Because of the
obscurity of its subcellular localization, we ﬁrst
expressed TRAIP as Flag-epitope fusion proteins to
determine where ectopically expressed TRAIP loca-
lizes. Interestingly, when the Flag epitope tag was fused
to its N-terminus, TRAIP concentrated into nuclear
punctate structures similar to those originally described
by Lee and colleagues [19]. Strikingly, when epitope-
tagged at its C-terminus, TRAIP predominantly
concentrated in nucleoli (Supplementary Figure S2A).
In support of its nucleolar localization, using rabbit
polyclonal antibodies that were raised against TRAIP
proteins, we found that endogenous TRAIP also
resided in nucleoli (Figure 2a and Supplementary
Figure S2B) [27–29]. To further understand the deter-
minants that promote TRAIP occupancy in nucleoli,
we generated a number of deletion mutants on the
TRAIP polypeptide and assessed their subcellular
localization (Figure 2b–d). Intriguingly, we found that
TRAIP RING mutants (ΔRING and C7A) did not
accumulate in nucleoli, but instead formed speckle-like
structures that are most prominent when the mutant
proteins are expressed at high levels. Indeed, protea-
somal inhibition increased the expression and the for-
mation of TRAIP ΔRING speckles, but not
that of wild-type TRAIP (Figure 2e). Together,
we concluded that TRAIP localizes in nucleoli, and
that the N terminus of TRAIP may be important in
regulating its nucleolar retention.
TRAIP is a PCNA-interacting factor
To explore how TRAIP protects genome integrity
and to deﬁne the TRAIP interactome in response to
replicative stress, we afﬁnity-puriﬁed TRAIP protein
complexes from 293T cells that have been engineered
to stably express streptavidin-binding peptide- and
S-tagged TRAIP. Mass spectrometric analysis of
TRAIP immunoprecipitates identiﬁed a cohort of
DNA replication and repair factors, including PCNA
(Figure 3a). Consistently, reciprocal pull-down experi-
ments conﬁrmed that TRAIP speciﬁcally interacted
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with PCNA (Figure 3b and c), and that pre-treating
cells with HU further enhanced the TRAIP–PCNA
interaction (Figure 3d).
In line with the observation that many PCNA-
interacting proteins bear PIP boxes via which they
bind to the DNA replication processivity factor, visual
Figure 1 TRAIP protects genome integrity. (a–d) Cells pre-treated with TRAIP-targeting siRNAs (siTRAIP-1 and siTRAIP-2) or
non-targeting control siRNAs (siCTR) were challenged with hydroxyurea (5 mM, 4 h) and were subsequently processed for
analysis of micronuclei formation frequencies (a), by western blotting to examine knockdown efﬁciencies (b), and frequency
of chromosome aberrations (c, d). For each treatment group, we counted a total of 200 nuclei (a) or4100 metaphase spreads
(c, d) from three independent experiments. We scored chromosome breaks and fusions as aberrations (c). *Po0.05 vs control.
(e) Cell-cycle distribution was determined in U2OS cells depleted of TRAIP. Cells pre-treated with indicated siRNAs were ﬁxed in
70% ethanol, stained with propidium iodide (PI), and were subjected to ﬂow-cytometric analysis. (f) γH2AX positivity was
determined in HU-challenged control or TRAIP-depleted cells by indirect immunoﬂuorescence staining experiments using rabbit
polyclonal anti-γH2AX antibodies. We scored cells positive for γH2AX when γH2AX foci420 per nucleus. Results (mean± s.e.m.)
were from three independent experiments with cell count n4200 each. *Po0.05 vs control. (g) Control or TRAIP-depleted cells
were subjected to different doses of HU treatment in the clonogenic survival assay. Cells seeded on 60 mm dishes were
incubated at indicated doses of HU-containing medium for 8 h. Results (mean± s.e.m.) were from three independent experiments
each performed in triplicates.
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inspection of the TRAIP polypeptide sequence led to
the identiﬁcation of an evolutionarily conserved PIP-
like sequence on TRAIP C-terminus (Figure 3e and f).
Consistent with a requirement of TRAIP PIP in
mediating its PCNA interaction, deletion of the puta-
tive PIP on TRAIP impaired its interaction with
PCNA (Figure 3g). Because TRAIP normally resides
in nucleoli we speculated that TRAIP may migrate out
of the nucleoli in response to replicative stress. This
would explain how HU potentiated the TRAIP–
PCNA interaction (Figure 3d). To test this possibility,
we pre-incubated cells with BrdU to facilitate
identiﬁcation of single-stranded DNA (ssDNA)
regions that arise during replicative stress [32]. We
performed BrdU labeling under native conditions,
and determined subcellular localization of TRAIP in
HU-challenged cells. Consistently, upon treatment
with HU, which slows down DNA synthesis and
uncouples it from the helicase activity that unwinds
double-strand DNAs ahead of the replication forks,
Figure 2 TRAIP resides in the nucleolus. (a) TRAIP localizes predominantly in the nucleoli. U2OS cells grown on coverslip were
ﬁxed with 3% PFA, permeabilized in 0.5% Triton X-100, and immuno-labeled for TRAIP and Ki-67. Nuclei were visualized by
4,6-diamidino-2-phenylindole (DAPI). (b–d) Subcellular localization of TRAIP and its mutants. U2OS cells grown on coverslips
were transiently transfected with indicated TRAIP cDNAs and thereafter processed for immunoﬂuorescence staining experiments
using anti-Flag (M2) antibodies. Schematic illustration of TRAIP full-length (FL) and mutants and a summary of their localization
are shown (d). ΔPIP has an 8 amino acid internal deletion (amino acids 460–466), whereas C7A and PIP* encode a Cys to Ala
and a Gln 460 Ala/Leu 463 Ala mutant, respectively. (e) Cells expressing TRAIP-Flag (or its RING deletion mutant; ΔRING) were
processed for indirect immunoﬂuorescence experiments following treatment with MG132 (10 μM, 4 h) as described for (b). Nuclei
were stained with DAPI.
The TRAIP-PCNA axis promotes genome stability
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Figure 3 TRAIP is a PCNA-interacting protein. (a) Illustration depicting the TRAIP interactome (identiﬁed from this study) is
shown. TRAIP protein complexes were afﬁnity puriﬁed and identities of TRAIP-co-purifying proteins were analyzed by mass
spectrometric analysis (LC/MS/MS). Relationships of PCNA and its established interacting partners are also displayed.
(b, c) TRAIP interacts with PCNA. Bacterially expressed and puriﬁed GST or GST-TRAIP fusion proteins were conjugated
onto afﬁnity matrix and incubated with 293T cell lysate. The GST–TRAIP–PCNA interaction was examined by western blotting
using indicated antibodies (b). His-tagged PCNA conjugated onto nickel agarose beads was incubated with lysates derived from
cells expressing Flag-epitope tagged TRAIP, SET8 or RNF8. Bound proteins were analyzed by western blotting experiments (c).
SET8 is a known PCNA-interacting protein and was used as a positive control. Note that expression constructs encoding
Flag-TRAIP, SET8 and RNF8 are fused with afﬁnity tags (Streptavidin binding peptide and S-protein tag; see Materials and
methods) and are of much large size. (d) Replicative stress enhanced the TRAIP–PCNA interaction. 293T cells pre-treated with
hydroxyurea (HU) (5 mM, 4 h) were lysed and co-immunoprecipitation experiments were used to examine the TRAIP–PCNA
interaction. Western blotting experiments were performed using indicated antibodies. (e) Domain organization of TRAIP and its
mutants. (f) Identiﬁcation and conservation of the PIP box on TRAIP. TRAIP-C-ΔPIP is an internal deletion mutant and has its
conserved PIP box (QAKLDTFLWS) removed. (g) TRAIP interacts with PCNA via its PIP. Bacterially expressed His-PCNA
proteins were incubated with lysates derived from cells expressing TRAIP and its various mutants (see Figure 2e). (h) TRAIP
migrates to HU-induced DNA lesions. Cells expressing TRAIP-Flag (or its PIP deletion mutant; ΔPIP) pre-labeled with 10 μM
BrdU for 24 h were treated with either HU or not, and were subsequently processed for indirect immuno-ﬂuorescence
experiments using anti-Flag (M2) and anti-BrdU (Rat) antibodies. Nuclei were stained with DAPI.
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TRAIP accumulated into punctate structures that
overlapped with ssDNAs at stalled forks (Figure 3h).
Translocation of TRAIP onto HU-induced ssDNA
stretches required its PIP box (Figure 3h), resembling
its pivotal role in supporting TRAIP accumulation at
laser-induced DNA damage tracks (Supplementary
Figure S3A–C). TRAIP also relocalized to γH2AX-
marked sites in response to other types of replicative
stress-inducing agents, including aphidicolin, mitomy-
cin C, UV radiation and cisplatin (Supplementary
Figure S3D). By contrast, TRAIP did not noticeably
accumulate at IR-induced DNA lesions. Together,
these data implicate a direct role of TRAIP, via its PIP,
at stressed replication forks.
TRAIP inactivation compromised replication
processivity
In light of the stress-inducible relocalization of
TRAIP onto stalled forks and its interaction with the
PCNA clamp, we speculated that TRAIP may be
important in repair of damaged forks. To this end,
we inactivated TRAIP using the RNA interference
approach, and analyzed fork progression by use of the
DNA combing method. Accordingly, we sequentially
labeled cells with thymidine analogs (IdU and CIdU) in
control and TRAIP-knockdown cells to compare
relative rates of DNA replication in the absence or
presence of HU. Interestingly, although TRAIP
deﬁciency did not noticeably affect DNA synthesis in
unperturbed cells, length of CIdU tracks, reﬂective of
DNA synthesis under stress, was substantially shorter
in TRAIP-depleted cells (Figure 4a and b), suggesting
that TRAIP deﬁciency compromises fork stability and
progression when nucleotide pool becomes limiting.
We also examined whether TRAIP may be required
for fork restart using the same methodology
(Figure 4c). Cells were ﬁrst labeled with IdU to control
for rates of unperturbed DNA synthesis. Following a
2-h hydroxyurea challenge, cells were incubated with
CIdU to assay fork restart and progression. Notably,
depletion of TRAIP resulted in much shorter CIdU
tracks over a wide dose range of hydroxyurea
treatment (Figure 4d and e), suggesting that TRAIP
inactivation hampered fork restart or stability.
Our observation that most forks restarted upon HU
withdrawal precludes complication that may arise from
fork collapsing (Supplementary Figure S4A-C), which
results only after prolonged HU treatment [33]. Indeed,
prolonged inhibition of de novo nucleotide synthesis
compromised fork restart irrespective of TRAIP status
(Supplementary Figure S4D–G).
To examine the functional relevance of the TRAIP–
PCNA interaction in promoting recovery of stalled
forks, we generated siRNA-resistant versions of
TRAIP (Supplementary Figure S5), and performed
reconstitution experiments in TRAIP-depleted cells.
Notably, in contrast to their wild-type counterparts,
cells expressing the PCNA-binding defective TRAIP
mutant (TRAIP-PIP*) displayed defects in fork
progression during cell recovery from HU challenge
(Figure 4f), and failed to alleviate the TRAIP
deﬁciency-associated increase in micronuclei formation
(Figure 4g). Taken together, these data highlight the
TRAIP–PCNA axis in repair and recovery of
HU-stalled forks.
TRAIP regulates PCNA level on chromatin
Replication inhibition triggers unloading of PCNA
from DNA replication factories [9–13]. Given the
importance of the TRAIP-PCNA interaction in repli-
cative stress responses, we explored whether TRAIP
may regulate chromatin binding of PCNA following
HU treatment. Noting that replication fork-associated
PCNA proteins at DNA replication factories can be
visualized by incorporating a pre-extraction step before
cell ﬁxation, we pre-extracted the soluble pool of
PCNA using 0.5% Triton X-100 solution before cells
were ﬁxed in methanol. Intriguingly, in sharp contrast
to control cells, where intensity of PCNA accumulation
at DNA replication factories was markedly reduced
when cells were challenged with HU (Figure 5a and
Supplementary Figure S6), this was not seen in cells
depleted of TRAIP (Figure 5a). Consistently, ﬂow-
cytometric analysis of the triton extraction-resistant
pool of PCNA also revealed an important role of
TRAIP in HU-induced PCNA unloading (Figure 5b
and c), suggesting that TRAIP may participate in
regulating PCNA unloading from chromatin during
replicative stress.
Similar to yeast cells [14], HU-induced PCNA
unloading from chromatin required the DNA damage
kinases ATM and ATR (Supplementary Figure S7A–E),
although chemical inhibition of ATM/ATR did not
compromise TRAIP relocalization onto ssDNAs
(Supplementary Figure S7F). To further explore the
possibility of a role of TRAIP in promoting PCNA
unloading in response to replicative stress, we bio-
chemically fractionated chromatin-enriched fractions
from control and stressed cells, and assessed the level of
PCNA immediately after and following recovery from
HU treatment. Importantly, we found reproducibly
that chromatin-bound PCNA level was much reduced
in response to HU, and that it gradually recovered
The TRAIP-PCNA axis promotes genome stability
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Figure 4 TRAIP inactivation compromises DNA synthesis during replicative stress. (a, b) TRAIP-depleted cells displayed
reduced rates of fork progression under replicative stress. Cells pre-treated with TRAIP-targeting siRNAs (siTRAIP-1 and
siTRAIP-2) or control siRNAs (siCTR) were sequentially labeled with IdU then with CIdU in the presence of 5 mM hydroxyurea
(HU). Western blotting experiments were performed to assess TRAIP silencing efﬁciency using anti-TRAIP antibodies. KAP1 was
used as a loading control (a). DNA combing assays were performed to examine DNA synthesis, and length of CIdU tracks was
determined (b) from three independent experiments. Note that IdU tracks did not differ among the treatment groups. (c–e) TRAIP
promotes recovery of stalled forks. Schematic depicting experimental procedures involving sequential labeling with IdU and CIdU
(c). DNA from cells pre-treated with TRAIP-speciﬁc siRNAs (siTRAIP-1 and siTRAIP-2) or control siRNAs (siCTR) was combed
and immuno-labeled to determine fork progression with (+HU; 10 mM, 2 h) or without HU (−HU) treatment (d, e). Quantiﬁcation of
CIdU-labeled tracks relative to IdU tracks is shown for a range of HU doses. *Po0.05 vs control. (f) TRAIP promotes DNA
replication restart via its PIP. Cells expressing siRNA-resistant TRAIP cDNAs (TRAIP-Flag or its PIP* mutant) were transfected
with indicated siRNAs. As depicted in (c) cells were labeled with IdU, challenged with 10 mM HU (2 h), were labeled with CIdU
before they were lysed and processed to assay for DNA synthesis. ***Po0.05 vs control. Western blot showing expression of
TRAIP-Flag and mutant is shown. (g) Images showing micronuclei formation (arrow heads) in HU-challenged (5 mM, 4 h) cells
pre-treated with control siRNA (siCTR), TRAIP-targeting siRNAs (siTRAIP), or in cells reconstituted with siRNA-resistant TRAIP
cDNAs as in (f). Frequencies of micronuclei formation are shown. Results were derived from three individual experiments
(n = 200).
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upon HU withdrawal (Figure 5d). By contrast, TRAIP
inactivation impaired the HU-induced reduction
of PCNA on chromatin, and was coupled with
hyper-accumulation of ssDNA-binding protein RPA.
Hyper-accumulation of RPA was also observed in
TRAIP-depleted cells in response to a range of
replicative stress-inducing agents (Supplementary
Figure S8). Interestingly, the effect of chemical
inhibition of de novo nucleotide synthesis on PCNA
unloading from chromatin was dose dependent, and
Figure 5 TRAIP promotes PCNA unloading in response to replication inhibition. (a) U2OS cells transfected with indicated siRNAs
were grown on coverslips, and were either incubated with 5 mM hydroxyurea (+HU) or left untreated (−HU) for 4 h. Cells were
subsequently processed for indirect immunoﬂuorescence experiments using anti-PCNA and anti-γH2AX antibodies. Nuclei were
visualized by DAPI staining. (b) U2OS cells transfected with indicated siRNAs were either incubated with 5 mM HU (+HU) or left
untreated (−HU) for 1 h. Cells were trypsinized, permeabilized in 0.5% Triton X-100 for 10 s and thereafter ﬁxed in methanol. To
detect chromatin-bound PCNA, cells were labeled with anti-PCNA antibodies. Processed cells were analyzed by ﬂow cytometry,
and cells positive for PCNA are shown in percentages. (c) Representative blot showing siRNA-mediated TRAIP knockdown in
U2OS cells. (d) U2OS cells pre-treated with TRAIP-targeting siRNAs were incubated with HU (10 mM, 2 h) and released. Cells
were harvested at indicated time points, and were biochemically fractionated to determine PCNA level on chromatin-enriched
fractions. (e) U2OS cells were transfected with indicated siRNAs and were incubated with 0, 2 or 10 mM HU for 2 h. Cells were
processed as in (d). (f) U2OS cells or derivatives that express siRNA-resistant versions of TRAIP (full-length, FL or PIP*) cDNAs
were transfected twice with TRAIP-targeting siRNAs (siTRAIP-1) or control (siCTR) at 24 h intervals. Forty-eight hours post
transfection, cells were challenged with 10 mM HU for 2 h. Whole cell extract (WCE) and chromatin-enriched fractions were
prepared, and were processed for western blotting analysis using indicated antibodies.
The TRAIP-PCNA axis promotes genome stability
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was inversely proportional to RPA loading (Figure 5e).
It is noteworthy to mention that the PCNA and RPA
dynamics at stressed forks observed in these experi-
mentations share striking similarities to those observed
previously in live cells at single-cell level [10]. Given the
requirement of TRAIP PIP in its PCNA targeting,
we performed reconstitution experiments in TRAIP-
knockdown cells to assay the functional relevance of
the TRAIP–PCNA interaction. Using biochemical
fractionation approach to monitor chromatin-bound
PCNA, we found that HU-regulated PCNA unloading
also required the TRAIP PIP box (Figure 5f),
highlighting a requirement for PCNA targeting in this
process in vivo. Together, these data implicate TRAIP
in regulating stress-induced PCNA turnover at
replication forks.
Our observation that replicative stress triggered
substantial reduction of PCNA from stalled forks,
together with the prior knowledge that TRAIP encodes
an active E3 ubiquitin ligase prompted us to speculate
whether TRAIP may ubiquitylate and promote PCNA
turnover. Given that mutations of TRAIP RING
perturbed its subcellular localization, which precluded
us from directly examining its functionality in vivo,
we chemically inhibited the proteasome using MG132
and assayed for recovery of stalled forks in cells.
We reasoned that whether TRAIP promotes PCNA
ubiquitylation and turnover, proteasome inhibition
should mimic TRAIP inactivation, and should
exacerbate the HU-induced defects in fork progression
and recovery. Despite established roles of the ubiquitin
proteasome pathways in cell-cycle control regulation,
transient inhibition of the proteasome did not
exacerbate HU-induced fork stalling (Supplementary
Figure S9), although it did reveal that TRAIP expres-
sion is kept at low levels in cells (Supplementary
Figure S10). Failure to limit TRAIP activity, perhaps
by restricting its nucleolar residency, may trigger
unscheduled PCNA unloading. Interestingly, cells
seem to have evolved strategies to sequester
unrestrained TRAIP proteins into nuclear bodies that
do not overlap with known entities (Figure 2 and
Supplementary Figure S2A) [19].
Discussion
Serving a master scaffolding role at DNA replica-
tion forks the PCNA clamp is dynamically regulated
to coordinate processive DNA replication with trans-
lesion synthesis and checkpoint activation. In this
study, we have identiﬁed TRAIP as a novel PCNA-
interacting factor that promotes recovery of damaged
forks. TRAIP bears a PIP-like motif at its C-terminus
(Figure 3e and f), relocalizes to stress-induced ssDNAs
(Figure 3h) and γH2AX-marked DNA lesions
(Supplementary Figure S3D), and targets PCNA to
facilitate its turnover from chromatin (Figure 5).
Consistent with a direct role at damaged forks, TRAIP
inactivation resulted in severely compromised DNA
synthesis during nucleotide scarcity (Figure 4), which
in turn jeopardized genome stability (Figure 1 and
Supplementary Figure S1). Together, our ﬁndings
uncover TRAIP as a component of the mammalian
replicative stress response network, and implicate
dynamic PCNA turnover as a TRAIP-dependent
mechanism in promoting faithful duplication of the
genetic material.
The nucleolus serves as a reservoir for many DDR
proteins, including the Werner’s syndrome gene
product [34]. Interestingly, our ﬁndings that TRAIP
proteins concentrate in nucleoli in a RING-dependent
manner raise the exciting possibility that the E3
ubiquitin ligase signature motif, rather than serving
catalytic roles, may provide a structural scaffold to
promote TRAIP occupancy in these subcellular com-
partments (Figure 2b and e). This notion is further
corroborated by the fact that N-terminally tagged
TRAIP fusion proteins, in sharp contrast to its
C-terminally tagged counterparts, are mislocalized
(Supplementary Figure S2A). Although it has been
reported to enhance ubiquitylation of a translesion
polymerase [27], our ﬁndings that TRAIP RING is
required for its proper subcellular localization pre-
cluded us from testing directly whether its E3 ubiquitin
ligase activity may be important for its functionality in
recovery of damaged forks, as RING-inactivated
TRAIP mutants have lost their inducibility to trans-
locate from nucleoli to stressed forks, and is further
complicated by their tendency to form nuclear punctae
of unknown nature (Figure 2b and e). Following this
argument, while we note that the TRAIP deﬁciency-
associated increase in micronuclei formation frequency
was suppressed by the re-introduction of wild-type
TRAIP, but not its RING-inactivated mutant
(Supplementary Figure S11A), further experimenta-
tions will be necessary to ascribe a direct role of TRAIP
RING in replicative stress responses. As TRAIP
inactivation did not noticeably affect the level of
ubiquitylated PCNA in response to replicative stress
(Supplementary Figure S11B), and that proteasome
inhibition did not compromise fork recovery upon
relief of replicative stress conditions (Supplementary
Figure S9), we favor the model in which TRAIP may
promote PCNA unloading in a non-catalytic manner
Wanjuan Feng et al.
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(Figure 6). Notably, the idea that E3 ubiquitin ligases
also serve non-catalytic roles is not unprecedented
among enzymes in the RING family [26, 35, 36].
Anyhow, given that emerging link between replicative
stress and fork dissociation of PCNA [9–13, 37], it will
be of signiﬁcant interest to deﬁne mechanistically how
TRAIP participates in this process.
Our analysis of the TRAIP interactome highlighted
important roles of TRAIP in DNA replication
processes. Indeed, not only does TRAIP interact with
the core DNA replication factor PCNA (Figure 3),
inactivation of TRAIP, or its interaction with PCNA,
compromised DNA synthesis at times of nucleotide
shortage (Figure 4). It is noteworthy to mention,
however, that our identiﬁcation of the TRAIP–PCNA
axis in replicative stress responses does not exclude the
possibility that TRAIP may also participate in driving
ordered cell progression through mitosis as reported
recently by the Huber and Kim laboratories, despite of
the discrepancies of the two studies [28, 38]. Notably,
our ﬁnding that mitotic indices of TRAIP-depleted cell
populations did not noticeably differ from control cells
is in general agreement with those described by Huber
and co-workers, although the authors also proposed
a positive role of TRAIP in the spindle assembly
checkpoint [28].
To ensure faithful duplication of its genetic material,
cells have evolved various DNA repair and tolerance
pathways to accommodate many different types of
DNA damage during DNA replication. As such, one
could envisage that nucleotide shortage and damaged
DNA templates may trigger very different responses at
replication forks. Indeed, it has become clear that
chemical inhibition of de novo nucleotide synthesis
leads to active PCNA unloading from replication
compartments [9–12], whereas similar observation is
not seen in cells in response to UV irradiation.
Importantly, and as pointed out by Dobrucki and
colleagues [37], given the established roles of PCNA in
DNA repair, the differences in PCNA foci dynamics
could be a result of the need to mobilize and reload
PCNA for repair of certain types of DNA lesions, and
warrants a more in-depth study of TRAIP and PCNA
dynamics at DNA replication factories. Nevertheless,
our ﬁndings that TRAIP relocalizes in response to a
range of genotoxic agents clearly suggest broader
roles of the E3 ubiquitin ligase in the mammalian
cell responses to replicative stress (Supplementary
Figure S3D).
Although PCNA unloading is clearly an important
molecular event at stressed replication forks, it remains
obscure why PCNA clamps need to be cleared from the
scene. One possibility is that defective unloading of
PCNA impairs its recycling, limits its availability and
in turn slows down fork progression. Alternatively, one
may speculate that stress-induced PCNA unloading
may be coupled to fork remodeling [16], which in
turn may facilitate replication fork reversal and restart
[39, 40]. This model would predict that failure to
efﬁciently unload PCNA from stressed replication
forks compromises fork remodeling, and would
negatively regulate restart of DNA replication.
Problematic fork recovery can also contribute to
Figure 6 Working model depicting how TRAIP participates in
regulating PCNA unloading from stressed replication forks. PCNA
is dynamically loaded and unloaded at replication forks in
proliferating cells (a). TRAIP senses nucleotide shortage and
translocates to stressed replication forks where it promotes PCNA
unloading via an undeﬁned mechanism (b). In the absence of
TRAIP, PCNA turnover from chromatin is perturbed and DNA
synthesis is compromised (c).
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under-replicated DNA and consequently genome
instability. Although this model remains to be deﬁni-
tively tested, our data clearly showed that TRAIP
inactivation hampered fork restart and progression
during and upon recovery from HU challenge
(Figure 4), and that TRAIP depletion resulted in
hyper-accumulation of ssDNA-binding protein RPA
on chromatin (Figure 5d and e, Supplementary
Figure S8). Given the intimate links of PCNA and
DNA repair, and the TRAIP-PCNA interaction in the
dynamic regulation of PCNA on chromatin, it would
be of signiﬁcant interest to explore how TRAIP
mutations may contribute to clinical manifestations of
human DNA repair disorder, including the recently
described primordial dwarﬁsm [41].
Materials and methods
Antibodies and chemicals
The TRAIP polyclonal antibody was raised against
GST-TRAIP-N terminal fusion protein (see Figure 3e) and
afﬁnity puriﬁed using column coated with MBP-TRAIP-N
terminal fusion protein. Antibody speciﬁcally recognizing
γH2AX was previously described [42]. The anti-PCNA (PC10)
and anti-CHK1 (G-4) antibodies were from Santa Cruz
(Dallas, TX, USA); anti-Ki67 antibodies were from Chemicon
(Darmstadt, Germany); anti-RPA1 antibodies were from Cal-
biochem (Darmstadt, Germany); anti-Chk1-pS345 antibodies
were from Cell Signaling (Danvers, MA, USA); anti-KAP1
antibodies were from BD Transduction Laboratories (San Jose,
CA, USA). Anti-Actin, anti-GFP and anti-Flag (M2) antibodies
were obtained from Sigma (Darmstadt, Germany). ATMi
(KU55993) and ATRi (VE821) inhibitors were from Sell-
eckChem (Houston, TX, USA).
Tandem afﬁnity puriﬁcation
Afﬁnity puriﬁcation of TRAIP protein complexes was
carried out essentially as described previously [43]. Brieﬂy,
293T cells expressing TRAIP with C-terminally tagged with
streptavidin binding peptide-S peptide-Flag (SFB) were treated
with 5 mM HU for 4 h, harvested and lysed in NETN buffer
(100 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl pH 8 and 0.5%
Nonidet P-40) for 15 min on ice. Supernatant containing
TRAIP–protein complexes was puriﬁed by sequential binding to
streptavidin sepharose (Amersham Bioscience, Pittsburgh, PA,
USA) and S protein agarose (Novagen, Darmstadt, Germany),
and was subjected to mass spectrometric analysis (LC/MS/MS)
at Taplin Mass Spectrometry Facility (Harvard).
Cell culture and transfection
U2OS, HeLa and 293T cells (or their derivatives) were
cultured in DMEM supplemented with 10% fetal calf serum and
maintained in 5% CO2 at 37 °C. Cell transfection was performed
using Polyethylenimine (PEI; Polysciences Inc., Warringston,
PA, USA).
Small-interfering RNAs
siRNAs targeting TRAIP or non-targeting control siRNAs
(Dharmacon, Lafayette, CO, USA) were transfected twice at
24-h intervals using Oligofectamine (Invitrogen, Carlsbad, CA,
USA). The TRAIP siRNA sequences are CAG ACA GUC
UAC UCU GAA UTT (siTRAIP-1) and CAG CAU GGU
UAC UAC GAA ATT (siTRAIP-2). siRNAs were used at a
ﬁnal concentration of 100 nM.
Protein–protein interacting studies
To examine the interaction between TRAIP and PCNA,
GST-TRAIP and GST were expressed and puriﬁed from BL21
bacterial cells using standard procedures, conjugated onto GST
beads, and were incubated with lysates derived from 293T cells
at 4 °C for 4 h. Beads were washed twice with NETN buffer.
Proteins were eluted by boiling in Laemmli sample buffer,
separated by SDS-PAGE, and immunoblotting experiments
were performed. For histidine (HIS) tagged-PCNA pulldown
experiments, constructs encoding Flag-tagged TRAIP and its
mutants were transiently transfected into 293T cells. Cells were
lysed in NETN buffer, cleared by centrifugation before they
were incubated with puriﬁed His-PCNA on nickel beads for 4 h
at 4 °C. Beads were subsequently washed, boiled in Laemmli
sample buffer, separated by SDS-PAGE and immunoblotted
with the indicated antibodies. To detect the endogenous
TRAIP-PCNA complex, 293T cells pre-treated with or without
HU (5 mM, 4 h) were lysed, and immunoprecipitation was
performed using anti-TRAIP sera or pre-bleed control.
Immunostaining procedure
Unless otherwise stated, cells grown as monolayers on
coverslips were permeabilized in 0.5% Triton X-100 solution for
10 s, following by ﬁxation in 3% paraformaldehyde at room
temperature for 15 min. Nuclei were visualized by staining
with DAPI. Images were acquired using an Olympus BX51
ﬂuorescence microscope (Tokyo, Japan). To visualize PCNA
replication foci or for examination of chromatin-bound PCNA
by ﬂow cytometry, cells were pre-extracted with 0.5% Triton
X-100 solution for 10 s followed by a 20-min methanol ﬁxation
step at − 20 °C.
DNA ﬁber assays
U2OS cells were sequentially labeled with IdU (50 μM) and
CidU (100 μM). Thereafter, labeled cells were harvested and
DNA ﬁber spreads were prepared on silanized slides (DAKO,
Santa Clara, CA, USA) by addition of 200 mM Tris-HCl pH 7.5,
50 mM EDTA, 0.5% SDS [44]. We ﬁxed and denatured DNA
ﬁbers using methanol/acetic acid (3:1), and 2.5 M HCl, respec-
tively. The acid-treated ﬁber spreads were subsequently neu-
tralized with Borax buffer (0.1 M borax, pH 8.5), and co-stained
with mouse anti-BrdU antibodies (BD Biosciences, clone B44;
diluted at 1:100) and rat anti-BrdU antibodies (AbD Serotec,
Hercules, CA, USA, clone BU1/75; diluted at 1:100). Secondary
antibodies were Rhodamine goat anti-mouse IgG and FITC
goat anti-rat IgG (both from Jackson ImmunoResearch
Laboratories, West Groves, PA, USA; diluted at 1:400). Fibers
were examined under ﬂuorescence microscope. For quantiﬁca-
tion of replication structures, at least 250 structures were
counted per experiment. The relative lengths of red
Wanjuan Feng et al.
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(Rhodamine) and green (FITC) labeled patches were measured
using the ImageJ software (National Institutes of Health; http://
rsbweb.nih.gov/ij).
Laser microirradiation
To generate localized DNA damage, cells were plated
on glass-bottomed dishes (World Precision Instruments Inc.,
Sarasota, FL, USA) and pre-sensitized with 10 μM 5-bromo-2′-
deoxyuridine (BrdU; Sigma-Aldrich) for 24 h at 37 °C. We
performed laser microirradiation by using an inverted confocal
microscope (LSM 510 Meta; Carl Zeiss, Inc., Oberkochen,
Germany) equipped with a multiphoton system with single scan
iteration at 800 nm, 10% output power of 1 800 mW. Cells were
imaged with a × 63 Plan-Apochromat/1.4 NA oil objective.
Time-lapse microscopy
H2B-GFP expressing HeLa cells were seeded, and were
transfected with control or TRAIP siRNAs. Twenty-four hours
post transfection cells were placed in a live cell stage-mounted
environment chamber and images were captured at 5 min
intervals using Perkin Elmer Spinning Confocal Microscope
(Waltham, MA, USA) for 8 h. Data were analyzed using the
MetaMorph analysis software (Sunnyvale, CA, USA).
Metaphase spreads
HeLa cells were treated with 0.5 μM nocodazole for 4 h and
lysed with 75 mMKCl in 37 °C for 30 min. Cells were ﬁxed on ice
with a 3:1 methanol/acetic acid solution. Cell were then dropped
onto slides, allowed to dry and were stained with Giemsa Stain
(Gibco, Waltham, MA, USA). Numbers of chromosome aber-
rations per metaphase were counted. We scored chromosome
breaks and fusions as chromosome aberrations.
Cell-cycle analyses
U2OS cells were trypsinized and ﬁxed with 70% ethanol.
Cells were washed with PBS, incubated with RNAse for 30 min
at 37 °C, and stained with propidium iodide for 10 min. Cell-
cycle distribution was determined using a BD FACSCantoII
Analyzer (San Jose, CA, USA).
Protein puriﬁcation
PCNA was expressed in BL21 cells and puriﬁed using metal
chelate afﬁnity chromatography via an N-terminal His-tag.
Brieﬂy, harvested cell pellet was resuspended in lysis buffer
(20 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole, 10%
(v/v) glycerol, 1 mM PMSF) and lysed by sonication. After
centrifugation, the supernatant was applied to a 1-ml Ni-NTA
resin pre-equilibrated with lysis buffer. The resin was washed
extensively with lysis buffer, followed by additional 10-column
volumes of lysis buffer containing 40 mM imidazole. Proteins
were eluted with 300 mM imidazole in lysis buffer. Pooled
fractions were buffer-exchanged and concentrated using a 30 K
MWCO concentrator (Millipore Corporation, Billerica, MA,
USA). Puriﬁed proteins were divided into small aliquots, snap-
frozen in liquid nitrogen and stored at − 80 °C until use.
Chromatin fractionation
To examine chromatin-bound PCNA, cells were pre-extract
with NETN buffer for 15 min on ice (soluble fraction).
Thereafter, the pellet was solubilized with NETN buffer
supplemented with Turbonuclease (chromatin-enriched
fraction).
Statistical analysis
Where appropriate, Student’s t-test was used to evaluate
potential differences between control and treatment groups.
We reported statistical signiﬁcance at Po0.05.
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